Skip to main content
🎗️
Oncology / Cancer Centre7 min read📅 1 May 2026

Unleashing Your Body's Power: Immunotherapy, India's New Cancer Frontier

P

Prof. Dr. S. Rajasundaram

Surgical Oncology · Iswarya Hospital

Discover how immunotherapy harnesses your immune system to fight cancer, offering new hope and personalized treatment options in Chennai.

For decades, the fight against cancer has primarily relied on traditional methods like surgery, chemotherapy, and radiation therapy. While these treatments have saved countless lives, they often come with significant side effects and limitations. Today, we stand at the cusp of a revolutionary era in oncology, where science is unlocking the incredible power of our own bodies to combat cancer. This breakthrough is known as immunotherapy.

Immunotherapy represents a paradigm shift, moving beyond directly attacking cancer cells to instead empower the patient's immune system to recognize and destroy these rogue cells. It's a highly sophisticated approach that has transformed the landscape for many types of cancer, offering new hope and improved outcomes for patients in India and worldwide.

What is Immunotherapy and How Does It Work?

At its core, immunotherapy is a treatment designed to boost or restore the immune system's ability to fight cancer. Our immune system is constantly on patrol, identifying and eliminating foreign invaders and abnormal cells, including early cancer cells. However, cancer cells are cunning; they often develop ways to evade detection or shut down the immune response, allowing them to grow unchecked.

Immunotherapy intervenes by:

  • Releasing the Brakes: Some immunotherapy drugs, called immune checkpoint inhibitors, block specific proteins (checkpoints) on immune cells or cancer cells that act as 'brakes' on the immune system. By releasing these brakes, the immune cells (T-cells) are unleashed to attack cancer more effectively.
  • Putting on the Gas: Other immunotherapies stimulate the immune system to work harder, or provide it with additional components, like lab-grown antibodies or modified immune cells (such as CAR T-cells, a cutting-edge therapy where a patient's T-cells are genetically engineered to better recognize and kill cancer cells).
  • Targeting Specific Markers: Some treatments use monoclonal antibodies that specifically bind to cancer cells, marking them for destruction by the immune system or directly interfering with their growth signals.

Unlike chemotherapy, which broadly attacks rapidly dividing cells (both cancerous and healthy), immunotherapy is often more targeted. Its goal is to teach your own immune system to be the most effective and precise weapon against your specific cancer.

Who Can Benefit from Immunotherapy?

While immunotherapy is a groundbreaking advancement, it's important to understand that it's not a universal cure for all cancers, nor is it suitable for every patient. Its effectiveness varies significantly depending on the type of cancer, its stage, and the patient's individual characteristics. However, for certain cancers, immunotherapy has yielded remarkable and often durable responses.

Immunotherapy has shown significant success and is approved for treating a growing list of cancers, including:

  • Melanoma: A type of skin cancer.
  • Lung Cancer: Both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
  • Kidney Cancer (Renal Cell Carcinoma):
  • Head and Neck Squamous Cell Carcinoma:
  • Bladder Cancer:
  • Hodgkin Lymphoma and some Non-Hodgkin Lymphomas:
  • Certain types of Colorectal Cancer: Especially those with specific genetic markers (MSI-High/dMMR).
  • Liver Cancer:
  • Merkel Cell Carcinoma: A rare, aggressive skin cancer.
  • Certain Stomach and Esophageal Cancers:

The decision to use immunotherapy involves a thorough evaluation by an oncology specialist. This often includes biomarker testing on tumor tissue to identify specific genetic mutations or protein expressions that indicate a higher likelihood of response to immunotherapy. This personalized approach ensures that the right treatment is chosen for the right patient, maximizing efficacy and minimizing unnecessary side effects.

What to Expect: The Immunotherapy Journey

Embarking on immunotherapy involves understanding the process and what to anticipate. Here's a general overview:

Treatment Administration

Most immunotherapies are administered intravenously (through an IV drip) in cycles, typically every 2-4 weeks. Each infusion session can last from 30 minutes to a few hours. The duration of treatment varies, ranging from several months to a couple of years, and sometimes even longer, depending on the specific drug, cancer type, and patient response.

Potential Side Effects (Immune-Related Adverse Events - irAEs)

One of the key differences from traditional chemotherapy is the nature of side effects. Immunotherapy side effects, known as immune-related adverse events (irAEs), occur when the supercharged immune system mistakenly attacks healthy tissues in the body. While generally less severe than chemotherapy side effects, they can range from mild to serious and affect almost any organ system.

Common irAEs include:

  • Fatigue: A feeling of extreme tiredness.
  • Skin reactions: Rash, itching.
  • Gastrointestinal issues: Diarrhea, colitis (inflammation of the colon) leading to abdominal pain.
  • Endocrine problems: Inflammation of the thyroid (hypothyroidism or hyperthyroidism), adrenal glands, or pituitary gland.
  • Liver inflammation (hepatitis):
  • Lung inflammation (pneumonitis): Causing cough or shortness of breath.
  • Musculoskeletal pain: Joint pain or muscle aches.

When to See a Doctor Immediately: Important Symptoms to Watch For

While many irAEs are manageable, some require urgent medical attention. It is crucial to report any new or worsening symptoms to your oncology team without delay. Do not try to manage these symptoms on your own.

  • Severe or persistent diarrhea: More than 4-6 bowel movements a day, bloody stools.
  • New or worsening shortness of breath or persistent cough:
  • Severe abdominal pain, dark urine, or yellowing of skin/eyes (jaundice):
  • Significant changes in vision or persistent headaches:
  • Unusual muscle weakness or numbness/tingling:
  • Persistent fever (over 100.4°F or 38°C) or chills:
  • Severe skin rash, blistering, or peeling:
  • Extreme fatigue that prevents daily activities:

Your care team will provide detailed guidance on recognizing and managing these side effects. Early detection and intervention are key to managing irAEs effectively and ensuring your safety during treatment.

Monitoring and Follow-up

Throughout your immunotherapy journey, regular blood tests and imaging scans (like CT or PET scans) will be conducted to monitor your response to treatment and check for any potential side effects. Close collaboration with your healthcare team is essential for a successful outcome.

The Promise and Challenges of Immunotherapy in India

Immunotherapy offers incredible promise for cancer patients in India. It brings the potential for:

  • Durable Responses: For some patients, immunotherapy can lead to long-lasting remissions, even in advanced cancers.
  • Improved Quality of Life: Compared to chemotherapy, some patients experience fewer debilitating side effects, allowing for a better quality of life during treatment.
  • Personalized Treatment: The increasing understanding of tumor biology allows for more tailored immunotherapy approaches.

However, there are also challenges, including the cost of these advanced therapies and the need for specialized expertise to administer and manage them. In India, access to these cutting-edge treatments is expanding, but it requires state-of-the-art facilities and a highly trained multidisciplinary team.

Iswarya Hospital is at the forefront of providing comprehensive cancer care in Chennai, offering advanced immunotherapy options as part of a holistic treatment plan. Our team of highly experienced surgical oncologists, medical oncologists, radiation oncologists, and supportive care specialists work together to evaluate each patient's unique situation and determine the most appropriate and effective treatment strategy, integrating immunotherapy where beneficial.

Conclusion

Immunotherapy has undeniably opened a new chapter in the fight against cancer, harnessing the body's innate defenses to achieve remarkable results. It represents not just a new treatment, but a new philosophy of cancer care – one that empowers the patient's own biology to heal. While it may not be a solution for everyone, for many, it offers a renewed sense of hope and the chance for a longer, healthier life.

If you or a loved one is facing a cancer diagnosis, understanding all available treatment options, including immunotherapy, is crucial. We encourage you to consult with a specialized oncology team to discuss whether this revolutionary treatment is right for you. At Iswarya Hospital, our dedicated experts are here to guide you through every step of your cancer journey with compassion and cutting-edge care.

Authored by: Prof. Dr. S. Rajasundaram, Surgical Oncology

Tags:

#Immunotherapy#Cancer Treatment#Oncology#Immune Checkpoint Inhibitors#Iswarya Hospital

Consult Our Oncology / Cancer Centre Specialists

Book an appointment with our expert team at Iswarya Hospital, OMR Chennai.

Explore our Oncology / Cancer Centre services →
📅 Book Now

Fill in the form or call us at 044 2025 2025

By submitting, you consent to being contacted by Iswarya Hospital.

044 2025 2025